vs
MERIT MEDICAL SYSTEMS INC（MMSI）与Rapid7, Inc.（RPD）财务数据对比。点击上方公司名可切换其他公司
MERIT MEDICAL SYSTEMS INC的季度营收约是Rapid7, Inc.的1.8倍（$381.9M vs $217.4M），MERIT MEDICAL SYSTEMS INC净利率更高（10.7% vs 1.4%，领先9.3%），MERIT MEDICAL SYSTEMS INC同比增速更快（7.5% vs 0.5%），Rapid7, Inc.自由现金流更多（$36.4M vs $24.7M），过去两年MERIT MEDICAL SYSTEMS INC的营收复合增速更高（6.3% vs 3.0%）
梅里特医疗系统公司是一家全球性医疗设备企业，设计、生产和销售适用于心脏病学、放射学、肿瘤学、内窥镜及重症监护领域的介入和诊断产品，为全球医院及医疗机构提供微创医疗解决方案，助力提升患者疗效和临床操作效率。
Rapid7是全球领先的网络安全企业，提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案，服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户，助力客户高效识别、应对和缓解网络安全风险。
MMSI vs RPD — 直观对比
营收规模更大
MMSI
是对方的1.8倍
$217.4M
营收增速更快
MMSI
高出6.9%
0.5%
净利率更高
MMSI
高出9.3%
1.4%
自由现金流更多
RPD
多$11.8M
$24.7M
两年增速更快
MMSI
近两年复合增速
3.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $381.9M | $217.4M |
| 净利润 | $41.0M | $3.1M |
| 毛利率 | 48.4% | 68.9% |
| 营业利润率 | 11.6% | 1.0% |
| 净利率 | 10.7% | 1.4% |
| 营收同比 | 7.5% | 0.5% |
| 净利润同比 | 36.0% | 44.1% |
| 每股收益（稀释后） | $0.68 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MMSIRPD
| Q1 26 | $381.9M | — | ||
| Q4 25 | $393.9M | $217.4M | ||
| Q3 25 | $384.2M | $218.0M | ||
| Q2 25 | $382.5M | $214.2M | ||
| Q1 25 | $355.4M | $210.3M | ||
| Q4 24 | $355.2M | $216.3M | ||
| Q3 24 | $339.8M | $214.7M | ||
| Q2 24 | $338.0M | $208.0M |
净利润MMSIRPD
| Q1 26 | $41.0M | — | ||
| Q4 25 | $38.0M | $3.1M | ||
| Q3 25 | $27.8M | $9.8M | ||
| Q2 25 | $32.6M | $8.3M | ||
| Q1 25 | $30.1M | $2.1M | ||
| Q4 24 | $27.9M | $2.2M | ||
| Q3 24 | $28.4M | $15.4M | ||
| Q2 24 | $35.7M | $6.5M |
毛利率MMSIRPD
| Q1 26 | 48.4% | — | ||
| Q4 25 | 49.6% | 68.9% | ||
| Q3 25 | 48.5% | 70.2% | ||
| Q2 25 | 48.2% | 70.6% | ||
| Q1 25 | 48.4% | 71.7% | ||
| Q4 24 | 48.7% | 69.5% | ||
| Q3 24 | 46.4% | 70.6% | ||
| Q2 24 | 47.7% | 70.7% |
营业利润率MMSIRPD
| Q1 26 | 11.6% | — | ||
| Q4 25 | 13.8% | 1.0% | ||
| Q3 25 | 11.1% | 2.7% | ||
| Q2 25 | 12.3% | 1.6% | ||
| Q1 25 | 11.5% | -0.0% | ||
| Q4 24 | 10.3% | 3.4% | ||
| Q3 24 | 11.0% | 6.0% | ||
| Q2 24 | 13.6% | 2.5% |
净利率MMSIRPD
| Q1 26 | 10.7% | — | ||
| Q4 25 | 9.6% | 1.4% | ||
| Q3 25 | 7.2% | 4.5% | ||
| Q2 25 | 8.5% | 3.9% | ||
| Q1 25 | 8.5% | 1.0% | ||
| Q4 24 | 7.9% | 1.0% | ||
| Q3 24 | 8.4% | 7.2% | ||
| Q2 24 | 10.6% | 3.1% |
每股收益（稀释后）MMSIRPD
| Q1 26 | $0.68 | — | ||
| Q4 25 | $0.64 | $0.05 | ||
| Q3 25 | $0.46 | $0.15 | ||
| Q2 25 | $0.54 | $0.13 | ||
| Q1 25 | $0.49 | $0.03 | ||
| Q4 24 | $0.46 | $0.08 | ||
| Q3 24 | $0.48 | $0.21 | ||
| Q2 24 | $0.61 | $0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $488.1M | $474.7M |
| 总债务越低越好 | $735.2M | — |
| 股东权益账面价值 | $1.6B | $154.7M |
| 总资产 | $2.7B | $1.7B |
| 负债/权益比越低杠杆越低 | 0.45× | — |
8季度趋势，按日历期对齐
现金及短期投资MMSIRPD
| Q1 26 | $488.1M | — | ||
| Q4 25 | $446.4M | $474.7M | ||
| Q3 25 | $392.5M | $407.1M | ||
| Q2 25 | $341.8M | $511.7M | ||
| Q1 25 | $395.5M | $493.5M | ||
| Q4 24 | $376.7M | $521.7M | ||
| Q3 24 | $523.1M | $443.7M | ||
| Q2 24 | $636.7M | $442.6M |
总债务MMSIRPD
| Q1 26 | $735.2M | — | ||
| Q4 25 | $734.0M | — | ||
| Q3 25 | $732.9M | — | ||
| Q2 25 | $731.8M | — | ||
| Q1 25 | $730.7M | — | ||
| Q4 24 | $729.6M | — | ||
| Q3 24 | $750.5M | — | ||
| Q2 24 | $801.3M | — |
股东权益MMSIRPD
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $154.7M | ||
| Q3 25 | $1.5B | $127.2M | ||
| Q2 25 | $1.5B | $90.4M | ||
| Q1 25 | $1.4B | $52.7M | ||
| Q4 24 | $1.4B | $17.7M | ||
| Q3 24 | $1.3B | $-5.1M | ||
| Q2 24 | $1.3B | $-52.6M |
总资产MMSIRPD
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $1.7B | ||
| Q3 25 | $2.6B | $1.7B | ||
| Q2 25 | $2.6B | $1.6B | ||
| Q1 25 | $2.5B | $1.6B | ||
| Q4 24 | $2.4B | $1.7B | ||
| Q3 24 | $2.4B | $1.6B | ||
| Q2 24 | $2.4B | $1.5B |
负债/权益比MMSIRPD
| Q1 26 | 0.45× | — | ||
| Q4 25 | 0.46× | — | ||
| Q3 25 | 0.48× | — | ||
| Q2 25 | 0.49× | — | ||
| Q1 25 | 0.51× | — | ||
| Q4 24 | 0.53× | — | ||
| Q3 24 | 0.57× | — | ||
| Q2 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $37.6M |
| 自由现金流经营现金流 - 资本支出 | $24.7M | $36.4M |
| 自由现金流率自由现金流/营收 | 6.5% | 16.8% |
| 资本支出强度资本支出/营收 | 4.2% | 0.5% |
| 现金转化率经营现金流/净利润 | — | 12.01× |
| 过去12个月自由现金流最近4个季度 | $220.8M | $146.2M |
8季度趋势，按日历期对齐
经营现金流MMSIRPD
| Q1 26 | — | — | ||
| Q4 25 | $98.5M | $37.6M | ||
| Q3 25 | $75.0M | $39.0M | ||
| Q2 25 | $83.3M | $47.5M | ||
| Q1 25 | $40.6M | $29.8M | ||
| Q4 24 | $68.7M | $63.8M | ||
| Q3 24 | $47.3M | $44.0M | ||
| Q2 24 | $68.5M | $32.9M |
自由现金流MMSIRPD
| Q1 26 | $24.7M | — | ||
| Q4 25 | $74.0M | $36.4M | ||
| Q3 25 | $52.5M | $34.8M | ||
| Q2 25 | $69.6M | $46.6M | ||
| Q1 25 | $19.5M | $28.4M | ||
| Q4 24 | $65.3M | $62.6M | ||
| Q3 24 | $38.0M | $42.6M | ||
| Q2 24 | $57.9M | $32.6M |
自由现金流率MMSIRPD
| Q1 26 | 6.5% | — | ||
| Q4 25 | 18.8% | 16.8% | ||
| Q3 25 | 13.7% | 16.0% | ||
| Q2 25 | 18.2% | 21.8% | ||
| Q1 25 | 5.5% | 13.5% | ||
| Q4 24 | 18.4% | 28.9% | ||
| Q3 24 | 11.2% | 19.9% | ||
| Q2 24 | 17.1% | 15.7% |
资本支出强度MMSIRPD
| Q1 26 | 4.2% | — | ||
| Q4 25 | 6.2% | 0.5% | ||
| Q3 25 | 5.8% | 1.9% | ||
| Q2 25 | 3.6% | 0.4% | ||
| Q1 25 | 5.9% | 0.6% | ||
| Q4 24 | 1.0% | 0.5% | ||
| Q3 24 | 2.8% | 0.6% | ||
| Q2 24 | 3.1% | 0.1% |
现金转化率MMSIRPD
| Q1 26 | — | — | ||
| Q4 25 | 2.59× | 12.01× | ||
| Q3 25 | 2.70× | 3.97× | ||
| Q2 25 | 2.56× | 5.70× | ||
| Q1 25 | 1.35× | 14.14× | ||
| Q4 24 | 2.46× | 29.36× | ||
| Q3 24 | 1.66× | 2.85× | ||
| Q2 24 | 1.92× | 5.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MMSI
暂无分部数据
RPD
| Products | $209.1M | 96% |
| Services | $8.2M | 4% |
